Research Article

Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids

Table 1

The patient characteristics.

Control group ()Patients with INS
Group I ()Group II ()Group III ()Group IV ()

Age (years)8.0 (7.00, 13.00)3.75 (3.25, 7.5)8.0 (5.5, 11)12.5 (10, 16)11.5 (7.6, 13.8)

Gender11 girls3 girls2 girls7 girls3 girls
9 boys5 boys5 boys8 boys17 boys

Data are presented as median values and interquartile ranges.